CX-929

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCX-929
Drug Alias NameCX-929
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsRett SyndromeFragile X SyndromeHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRespirerx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRespirerx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRett SyndromeFragile X SyndromeHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A